AllPennyStocks.com LXRX Stock Edges Higher On $10M Payout From Novo Nordisk — Retail Traders Highlight More Cash Milestones On The Horizon
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

LXRX Stock Edges Higher On $10M Payout From Novo Nordisk — Retail Traders Highlight More Cash Milestones On The Horizon

Lexicon announced the payment after Novo Nordisk hit a key patient-dosing target in the early-stage trial of LX9851.

Other Penny Stock Movers

Financial Tech Junior Surges 18% Following Reaffirmation of US$15.8M Digital Treasury
Quebec Gold Explorer Jumps 16% on C$57M Strategic Backing
$4.5 Million Could Unlock a Major Cannabis Market


Back to Top